Biden’s Approval Rating Plumbs New Depths
Bloomberg· 2 日前After staying pretty stable from mid-January until early May, President Joe Biden’s approval ...
Opinion | Congress’s Biotech Unicorn
The Wall Street Journal· 5 日前There’s enough private innovation if the feds don’t fix drug prices.